- Home
- BLSH vs RDY Comparison
BLSH vs RDY Comparison
Compare BLSH & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLSH
- RDY
- Stock Information
- Founded
- BLSH 2020
- RDY 1984
- Country
- BLSH Cayman Islands
- RDY India
- Employees
- BLSH N/A
- RDY N/A
- Industry
- BLSH Finance: Consumer Services
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- BLSH Finance
- RDY Health Care
- Exchange
- BLSH Nasdaq
- RDY Nasdaq
- Market Cap
- BLSH 10.2B
- RDY 11.6B
- IPO Year
- BLSH 2025
- RDY N/A
- Fundamental
- Price
- BLSH $64.89
- RDY $14.18
- Analyst Decision
- BLSH Buy
- RDY Strong Buy
- Analyst Count
- BLSH 11
- RDY 2
- Target Price
- BLSH $56.90
- RDY $16.95
- AVG Volume (30 Days)
- BLSH 4.9M
- RDY 942.8K
- Earning Date
- BLSH 09-17-2025
- RDY 11-04-2025
- Dividend Yield
- BLSH N/A
- RDY 0.50%
- EPS Growth
- BLSH N/A
- RDY 2.20
- EPS
- BLSH N/A
- RDY 0.79
- Revenue
- BLSH $259,164,241,000.00
- RDY $3,897,394,052.00
- Revenue This Year
- BLSH N/A
- RDY $7.33
- Revenue Next Year
- BLSH $29.61
- RDY $1.96
- P/E Ratio
- BLSH N/A
- RDY $17.68
- Revenue Growth
- BLSH 255.53
- RDY 15.86
- 52 Week Low
- BLSH $47.88
- RDY $12.26
- 52 Week High
- BLSH $118.00
- RDY $16.17
- Technical
- Relative Strength Index (RSI)
- BLSH N/A
- RDY 44.97
- Support Level
- BLSH N/A
- RDY $13.97
- Resistance Level
- BLSH N/A
- RDY $14.22
- Average True Range (ATR)
- BLSH 0.00
- RDY 0.19
- MACD
- BLSH 0.00
- RDY -0.06
- Stochastic Oscillator
- BLSH 0.00
- RDY 27.46
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.